Endoplasmic reticulum stress and inflammatory bowel disease.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 21861319)

Published in Acta Gastroenterol Belg on June 01, 2011

Authors

Lukas Niederreiter1, Arthur Kaser

Author Affiliations

1: Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.

Articles by these authors

Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest (2011) 2.93

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol (2007) 2.72

Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest (2006) 2.16

Paneth cells as a site of origin for intestinal inflammation. Nature (2013) 2.09

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology (2004) 2.02

ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells. J Exp Med (2013) 1.70

Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology (2009) 1.69

Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J Exp Med (2005) 1.57

Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med (2012) 1.50

Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest (2009) 1.49

CD1d function is regulated by microsomal triglyceride transfer protein. Nat Med (2004) 1.49

Clinical presentation of venous thromboembolism in inflammatory bowel disease. J Crohns Colitis (2012) 1.49

Obesity and the microbiota. Gastroenterology (2009) 1.49

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol (2003) 1.45

Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut (2013) 1.44

SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity (2006) 1.33

Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut (2010) 1.30

Crohn's disease: NOD2, autophagy and ER stress converge. Gut (2011) 1.27

Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol (2004) 1.26

Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology (2010) 1.23

Role of IL-10 for induction of anemia during inflammation. J Immunol (2002) 1.13

Treatment strategies in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol (2005) 1.13

Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J Leukoc Biol (2003) 1.12

Interferon-alpha controls IL-17 expression in vitro and in vivo. Immunobiology (2008) 1.07

Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. J Clin Invest (2010) 1.06

Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1. Blood Cells Mol Dis (2003) 1.03

How to modulate inflammatory cytokines in liver diseases. Liver Int (2006) 1.02

Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. J Immunol (2004) 1.02

The RANKL/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol (2005) 1.01

Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis. J Biol Chem (2014) 0.98

Novel insights into autoimmune liver diseases provided by genome-wide association studies. J Autoimmun (2013) 0.96

Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. Am J Physiol Gastrointest Liver Physiol (2005) 0.96

Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity. Am J Physiol Gastrointest Liver Physiol (2007) 0.95

Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease. Curr Opin Investig Drugs (2010) 0.95

Endoplasmic reticulum stress and inflammation. Dig Dis (2012) 0.91

Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease. Eur Cytokine Netw (2005) 0.90

Intramural duodenal hematoma after upper gastrointestinal endoscopy. Wien Med Wochenschr (2011) 0.89

Role of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol (2015) 0.88

Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. J Clin Immunol (2002) 0.87

DNA methylation analysis in the intestinal epithelium-effect of cell separation on gene expression and methylation profile. PLoS One (2013) 0.85

Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist. Eur Cytokine Netw (2005) 0.83

Sphingosine kinase-dependent migration of immature dendritic cells in response to neurotoxic prion protein fragment. J Virol (2003) 0.83

A key role for Pre-B cell colony-enhancing factor in experimental hepatitis. Hepatology (2011) 0.83

Deciphering the genetic predisposition to primary sclerosing cholangitis. Semin Liver Dis (2011) 0.82

Monoclonal antibody specific for TIRC7 induces donor-specific anergy and prevents rejection of cardiac allografts in mice. Am J Transplant (2004) 0.82

Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression? Eur Cytokine Netw (2009) 0.81

"ER stress(ed out)!": Paneth cells and ischemia-reperfusion injury of the small intestine. Gastroenterology (2010) 0.81

Mode of function of biological anti-TNF agents in the treatment of inflammatory bowel diseases. Expert Opin Biol Ther (2007) 0.80

Anti-IL-12/23 in Crohn's disease: bench and bedside. Curr Drug Targets (2013) 0.80

Type I interferons and their therapeutic role in Th2-regulated inflammatory disorders. Expert Opin Biol Ther (2004) 0.79

Neurokinin-1 receptor interacts with PrP(106-126)-induced dendritic cell migration and maturation. J Neuroimmunol (2005) 0.77

Controversy over NOD2, inflammation, and defensins. Inflamm Bowel Dis (2010) 0.77

Dead on arrival: understanding the failure of CTLA4-immunoglobulin therapy in inflammatory bowel disease. Gastroenterology (2012) 0.77

Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease. Scand J Gastroenterol (2008) 0.77

Antitumour necrosis factor therapy in Crohn's disease. Expert Opin Biol Ther (2002) 0.76

Seventeen in Crohn's disease: less prime than we thought? Gut (2012) 0.76

Interferon-alpha suppresses leptin levels: studies in interferon-alpha treated patients with hepatitis C virus infection and murine adipocytes. Eur Cytokine Netw (2002) 0.76

Genetic insights into non-anastomotic biliary strictures after orthotopic liver transplantation. Liver Int (2011) 0.75

The other way round: colitis regulates regulatory T cells. Gastroenterology (2004) 0.75

Adiponectin and JNK: metabolic/inflammatory pathways affecting gastrointestinal carcinogenesis. Gut (2009) 0.75

Message from the editors. United European Gastroenterol J (2014) 0.75

Introductory message from the Editors. United European Gastroenterol J (2013) 0.75

Innate immunity in gastrointestinal disorders: basic and therapeutic concepts. Dig Dis (2012) 0.75